Medicine and Dentistry
Patient
100%
COVID-19
74%
Malignant Neoplasm
53%
Patient with Cancer
40%
Infection
35%
Inpatient
28%
Mortality
27%
Therapeutic Procedure
23%
Hematologic Malignancy
21%
Hematopoietic Cell
20%
Diagnosis
19%
Transplantation
18%
Lower Respiratory Tract Infection
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Hispanic
16%
Association
15%
Cohort Analysis
15%
Vaccine
14%
Hematopoietic Stem Cell
14%
Odds Ratio
13%
Cancer Treatment
13%
Age
11%
All Cause Mortality
11%
Stem Cell Transplant
10%
Influenza
10%
Respiratory Syncytial Virus Infection
9%
Human Respiratory Syncytial Virus
9%
Breast Cancer
9%
Microbiome
9%
Ribavirin
9%
Incidence
8%
Viral Respiratory Tract Infection
8%
Morbidity
8%
Diseases
7%
Awareness
7%
Male
7%
Immunosuppressive Treatment
7%
Antiviral Therapy
7%
Prostate Cancer
7%
Surveillance
7%
Laboratory
6%
Logistic Regression Analysis
6%
Combination Therapy
6%
Cardiovascular System
6%
Human Metapneumovirus Infection
6%
Analysis
6%
Retrospective Study
6%
Upper Respiratory Tract Infection
6%
Cell Transplantation
5%
Mixed Infection
5%
Immunology and Microbiology
Transplantation
46%
Cells
45%
Human Respiratory Syncytial Virus
43%
Cytomegalovirus
32%
Mortality
32%
Lower Respiratory Tract
28%
Viral Disease
18%
Respiratory Syncytial Virus Infection
16%
Cytomegalovirus Infection
15%
Monospecific Antibody
15%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Immunodeficiency
13%
Ribavirin
13%
COVID-19
12%
Vaccine Efficacy
11%
Viral Clearance
10%
Influenza
9%
Hepatitis C Virus
9%
Cell Transplantation
9%
Morbidity
9%
Genotype
8%
Sample
8%
Upper Respiratory Tract
8%
Incidence
8%
Antibody Response
7%
Palivizumab
7%
Hematopoietic Stem Cell Transplantation
7%
Adoptive Immunity
6%
Dose
6%
Immunosuppression
6%
Human Respiratory Syncytial Virus A
6%
High Risk Population
6%
Coinfection
5%
Age
5%
Neutralizing Antibody
5%
All Cause Mortality
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lower Respiratory Tract Infection
24%
Malignant Neoplasm
21%
Mortality
19%
Ribavirin
17%
Human Respiratory Syncytial Virus
16%
Infection
15%
Hematologic Malignancy
14%
Respiratory Syncytial Virus Infection
14%
Drug
12%
Vaccine
11%
Immune Deficiency
10%
Malignant Neoplasm
9%
Cytomegalovirus
8%
Hepatitis C Virus
7%
Morbidity
7%
Cohort Study
6%
Upper Respiratory Tract Infection
6%
Viral Clearance
6%
Influenza
5%
Cytomegalovirus Infection
5%
Incidence
5%
All Cause Mortality
5%
Death
5%
